Rylander T, Neve EP, Ingelman-Sundberg M, Oscarson M (February 2001). "Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1)". Biochemical and Biophysical Research Communications. 281 (2): 529–35. Bibcode:2001BBRC..281..529R. doi:10.1006/bbrc.2001.4390. PMID11181079.
Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, Murray GI (May 2005). "Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis". Clinical Cancer Research. 11 (10): 3758–65. doi:10.1158/1078-0432.CCR-04-1848. PMID15897573. S2CID23287346.
Downie D, McFadyen MC, Rooney PH, Cruickshank ME, Parkin DE, Miller ID, Telfer C, Melvin WT, Murray GI (October 2005). "Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers". Clinical Cancer Research. 11 (20): 7369–75. doi:10.1158/1078-0432.CCR-05-0466. PMID16243809. S2CID37734580.
Frömel T, Kohlstedt K, Popp R, Yin X, Awwad K, Barbosa-Sicard E, Thomas AC, Lieberz R, Mayr M, Fleming I (January 2013). "Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques". Basic Research in Cardiology. 108 (1) 319. doi:10.1007/s00395-012-0319-8. PMID23224081. S2CID9158244.
Rylander T, Neve EP, Ingelman-Sundberg M, Oscarson M (February 2001). "Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1)". Biochemical and Biophysical Research Communications. 281 (2): 529–35. Bibcode:2001BBRC..281..529R. doi:10.1006/bbrc.2001.4390. PMID11181079.
Rylander T, Neve EP, Ingelman-Sundberg M, Oscarson M (February 2001). "Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1)". Biochemical and Biophysical Research Communications. 281 (2): 529–35. Bibcode:2001BBRC..281..529R. doi:10.1006/bbrc.2001.4390. PMID11181079.
Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, Murray GI (May 2005). "Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis". Clinical Cancer Research. 11 (10): 3758–65. doi:10.1158/1078-0432.CCR-04-1848. PMID15897573. S2CID23287346.
Downie D, McFadyen MC, Rooney PH, Cruickshank ME, Parkin DE, Miller ID, Telfer C, Melvin WT, Murray GI (October 2005). "Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers". Clinical Cancer Research. 11 (20): 7369–75. doi:10.1158/1078-0432.CCR-05-0466. PMID16243809. S2CID37734580.
Frömel T, Kohlstedt K, Popp R, Yin X, Awwad K, Barbosa-Sicard E, Thomas AC, Lieberz R, Mayr M, Fleming I (January 2013). "Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques". Basic Research in Cardiology. 108 (1) 319. doi:10.1007/s00395-012-0319-8. PMID23224081. S2CID9158244.
Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, Murray GI (May 2005). "Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis". Clinical Cancer Research. 11 (10): 3758–65. doi:10.1158/1078-0432.CCR-04-1848. PMID15897573. S2CID23287346.
Downie D, McFadyen MC, Rooney PH, Cruickshank ME, Parkin DE, Miller ID, Telfer C, Melvin WT, Murray GI (October 2005). "Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers". Clinical Cancer Research. 11 (20): 7369–75. doi:10.1158/1078-0432.CCR-05-0466. PMID16243809. S2CID37734580.
Frömel T, Kohlstedt K, Popp R, Yin X, Awwad K, Barbosa-Sicard E, Thomas AC, Lieberz R, Mayr M, Fleming I (January 2013). "Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques". Basic Research in Cardiology. 108 (1) 319. doi:10.1007/s00395-012-0319-8. PMID23224081. S2CID9158244.